Skip to main content
Top
Published in: Heart and Vessels 11/2019

01-11-2019 | Shock | Original Article

Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients

Authors: Kathrin Weidner, Michael Behnes, Christel Weiß, Christoph Nienaber, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Jonas Rusnak, Tobias Schupp, Seung-hyun Kim, Christian Barth, Jorge Hoppner, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin

Published in: Heart and Vessels | Issue 11/2019

Login to get access

Abstract

The study sought to assess the impact of chronic kidney disease (CKD) on recurrences of ventricular tachyarrhythmias in implantable cardioverter defibrillator (ICD) recipients. Data regarding the outcome of patients with CKD in ICD recipients is limited. A large retrospective registry was used including consecutive ICD recipients surviving episodes of ventricular tachycardia (VT) or fibrillation (VF) from 2002 to 2016. CKD patients were compared to non-CKD patients. The primary endpoint was the first recurrence of ventricular tachyarrhythmias at 5 years. Secondary endpoints were ICD-related therapies, rehospitalization and all-cause mortality at 5 years. Kaplan–Meier, multivariable Cox regression and propensity score matching were applied. A total of 585 consecutive patients were included (non-CKD: 57%, CKD: 43%). CKD had higher rates of the primary endpoint of recurrent ventricular tachyarrhythmias compared to non-CKD patients (50% vs. 40%; log rank p = 0.008; HR = 1.398; 95% CI 1.087–1.770; p = 0.009), which was irrespective of a primary or secondary preventive ICD and mainly attributed to recurrent VF (11% vs. 5%; p = 0.007) and electrical storm (ES) (10% vs. 5%; p = 0.010). Accordingly, CKD patients had higher rates of the secondary endpoint of appropriate ICD therapies (41% vs. 30%; log rank p = 0.002; HR = 1.532; 95% CI 1.163–2.018; p = 0.002), mainly attributed to appropriate ICD shocks (19% vs. 11%; p = 0.005). After multivariable Cox regression CKD was associated with a 1.4-fold higher risk of appropriate device therapies (HR = 1.353; 95% CI 1.001–1.825; p = 0.049), but not with first recurrence of ventricular tachyarrhythmias (p = 0.177). Irrespective of propensity score matching, CKD was associated with increasing all-cause mortality at 5 years (p = 0.001). The presence of CKD is associated with increased rates of recurrent ventricular tachyarrhythmias, appropriate device therapies, mainly attributed to appropriate shock, and all-cause mortality in ICD recipients at 5 years.
Literature
1.
go back to reference Zannad F, Rossignol P (2017) cardiovascular outcome trials in patients with advanced kidney disease: time for action. Circulation 135(19):1769–1771CrossRef Zannad F, Rossignol P (2017) cardiovascular outcome trials in patients with advanced kidney disease: time for action. Circulation 135(19):1769–1771CrossRef
2.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305CrossRef
3.
go back to reference Zannad F, Alonso Garcia MLA, Borer JS, Stough WG, Clutton-Brock T, Rosenberg Y, Packer M (2017) Role of payers in the development of cardiovascular therapeutics: misalignment between approval and reimbursement. J Am Coll Cardiol 70(22):2822–2830CrossRef Zannad F, Alonso Garcia MLA, Borer JS, Stough WG, Clutton-Brock T, Rosenberg Y, Packer M (2017) Role of payers in the development of cardiovascular therapeutics: misalignment between approval and reimbursement. J Am Coll Cardiol 70(22):2822–2830CrossRef
4.
go back to reference Charytan D, Kuntz RE (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 70(11):2021–2030CrossRef Charytan D, Kuntz RE (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 70(11):2021–2030CrossRef
5.
go back to reference Coca SG, Krumholz HM, Garg AX, Parikh CR (2006) Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296(11):1377–1384CrossRef Coca SG, Krumholz HM, Garg AX, Parikh CR (2006) Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 296(11):1377–1384CrossRef
6.
go back to reference McElwee SK, Velasco A (2016) Doppalapudi, mechanisms of sudden cardiac death. J Nucl Cardiol 23(6):1368–1379CrossRef McElwee SK, Velasco A (2016) Doppalapudi, mechanisms of sudden cardiac death. J Nucl Cardiol 23(6):1368–1379CrossRef
7.
go back to reference National Kidney F. KDOQI (2015) Clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66(5):884–930CrossRef National Kidney F. KDOQI (2015) Clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis 66(5):884–930CrossRef
8.
go back to reference Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, Eknoyan G, Kusek JW, Herzog C, Cheung AK, Sarnak MJ (2012) Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol 7(1):123–130CrossRef Shastri S, Tangri N, Tighiouart H, Beck GJ, Vlagopoulos P, Ornt D, Eknoyan G, Kusek JW, Herzog C, Cheung AK, Sarnak MJ (2012) Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol 7(1):123–130CrossRef
9.
go back to reference Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R, Investigators S (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 377(9784):2181–2192CrossRef Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R, Investigators S (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 377(9784):2181–2192CrossRef
10.
go back to reference Saad TF, Hentschel DM, Koplan B, Wasse H, Asif A, Patel DV, Salman L, Carrillo R, Hoggard J, Workgroup ACPC (2013) Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice. Semin Dial 26(1):114–123CrossRef Saad TF, Hentschel DM, Koplan B, Wasse H, Asif A, Patel DV, Salman L, Carrillo R, Hoggard J, Workgroup ACPC (2013) Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice. Semin Dial 26(1):114–123CrossRef
11.
go back to reference Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia, multicenter automatic defibrillator implantation trial investigators. N Engl J Med 335(26):1933–1940CrossRef Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia, multicenter automatic defibrillator implantation trial investigators. N Engl J Med 335(26):1933–1940CrossRef
12.
go back to reference Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337(22):1576–1583CrossRef Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337(22):1576–1583CrossRef
13.
go back to reference John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, Miller AL, Michaud GF, Stevenson WG (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380(9852):1520–1529CrossRef John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, Miller AL, Michaud GF, Stevenson WG (2012) Ventricular arrhythmias and sudden cardiac death. Lancet 380(9852):1520–1529CrossRef
14.
go back to reference Jung W, Andresen D, Block M, Bocker D, Hohnloser SH, Kuck KH, Sperzel J, V. Deutschen Gesellschaft fur Kardiologie–Herz- und Kreislaufforschung e, (2006) Guidelines for the implantation of defibrillators. Clin Res Cardiol 95(12):696–708CrossRef Jung W, Andresen D, Block M, Bocker D, Hohnloser SH, Kuck KH, Sperzel J, V. Deutschen Gesellschaft fur Kardiologie–Herz- und Kreislaufforschung e, (2006) Guidelines for the implantation of defibrillators. Clin Res Cardiol 95(12):696–708CrossRef
15.
go back to reference Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Multicenter automatic defibrillator implantation trial, prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRef Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Multicenter automatic defibrillator implantation trial, prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRef
16.
go back to reference Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J, Task F (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243–2278CrossRef Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J, Task F (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243–2278CrossRef
17.
go back to reference Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C (2006) Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, executive summary. Rev Esp Cardiol 59(12):1328PubMed Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C (2006) Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, executive summary. Rev Esp Cardiol 59(12):1328PubMed
18.
go back to reference Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC (2011) Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 58(3):409–417CrossRef Charytan DM, Patrick AR, Liu J, Setoguchi S, Herzog CA, Brookhart MA, Winkelmayer WC (2011) Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 58(3):409–417CrossRef
19.
go back to reference Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD (2007) Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30(2):207–213CrossRef Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD (2007) Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30(2):207–213CrossRef
20.
go back to reference Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R (2006) Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 3(10):1196–1201CrossRef Robin J, Weinberg K, Tiongson J, Carnethon M, Reddy M, Ciaccio C, Quadrini M, Hsu J, Fan J, Choi P, Kadish A, Goldberger J, Passman R (2006) Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients. Heart Rhythm 3(10):1196–1201CrossRef
21.
go back to reference Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SB, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL (2017) AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138:e272–e391 Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Hlatky MA, Granger CB, Hammill SB, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL (2017) AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138:e272–e391
22.
go back to reference Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Kardiol Pol 73(10):795–900CrossRef Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Kardiol Pol 73(10):795–900CrossRef
23.
go back to reference Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ, E.S.C.S.D. Group, (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867CrossRef Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ, E.S.C.S.D. Group, (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867CrossRef
24.
go back to reference Deneke T, Israel CW, Krug J, Nentwich K, Müller P, Mügge A, Schade A (2013) Indikationen zur Katheterablation bei ventrikulärer Tachykardie. Dtsch med Wochenschr 138(39):1952–1956CrossRef Deneke T, Israel CW, Krug J, Nentwich K, Müller P, Mügge A, Schade A (2013) Indikationen zur Katheterablation bei ventrikulärer Tachykardie. Dtsch med Wochenschr 138(39):1952–1956CrossRef
25.
go back to reference Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, ESC Committee for Practice Guidelines (2010) Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12(11):1526–1536CrossRef Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ, ESC Committee for Practice Guidelines (2010) Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 12(11):1526–1536CrossRef
26.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1–S155 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1–S155
27.
go back to reference Andrassy KM (2013) Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int 84(3):622–623CrossRef Andrassy KM (2013) Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int 84(3):622–623CrossRef
28.
go back to reference Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399–424CrossRef Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399–424CrossRef
29.
go back to reference Ferdinand D, Otto M, Weiss C (2016) Get the most from your data: a propensity score model comparison on real-life data. Int J Gen Med 9:123–131CrossRef Ferdinand D, Otto M, Weiss C (2016) Get the most from your data: a propensity score model comparison on real-life data. Int J Gen Med 9:123–131CrossRef
30.
go back to reference Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A, C. European Society of, P. European Association for Cardiovascular, Rehabilitation, N. Council on Cardiovascular, D. European Association for Study of, E. International Diabetes Federation, I. European Stroke, M. Society of Behavioural, H. European Society of, W. Europe, N. European Heart, S. European Atherosclerosis (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2):S1–S113CrossRef Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A, C. European Society of, P. European Association for Cardiovascular, Rehabilitation, N. Council on Cardiovascular, D. European Association for Study of, E. International Diabetes Federation, I. European Stroke, M. Society of Behavioural, H. European Society of, W. Europe, N. European Heart, S. European Atherosclerosis (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2):S1–S113CrossRef
31.
go back to reference Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JR, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task, G. European Society of Cardiology Committee for Practice, A. European Heart Rhythm, S. Heart Rhythm, ACC/AHA/ESC (2006) Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10):e385–e484CrossRef Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JR, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology/American Heart Association Task, G. European Society of Cardiology Committee for Practice, A. European Heart Rhythm, S. Heart Rhythm, ACC/AHA/ESC (2006) Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(10):e385–e484CrossRef
32.
go back to reference Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, Cozzolino M, Ronco C (2017) Pathophysiology of the cardio-renal syndromes types 1–5: an uptodate. Indian Heart J 69(2):255–265CrossRef Di Lullo L, Bellasi A, Barbera V, Russo D, Russo L, Di Iorio B, Cozzolino M, Ronco C (2017) Pathophysiology of the cardio-renal syndromes types 1–5: an uptodate. Indian Heart J 69(2):255–265CrossRef
33.
go back to reference Schwenger V, Remppis BA, Westenfeld R, Weinreich T, Brunkhorst R, Schieren G, Krumme B, Haller H, Schmieder R, Schlieper G, Frye B, Hoppe UC, Hoyer J, Keller T, Blumenstein M, Schunkert H, Mahfoud F, Rump LC (2014) Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group “heart-kidney” of the German Cardiac Society and the German Society of Nephrology. Dtsch Med Wochenschr 139(7):e1–e8CrossRef Schwenger V, Remppis BA, Westenfeld R, Weinreich T, Brunkhorst R, Schieren G, Krumme B, Haller H, Schmieder R, Schlieper G, Frye B, Hoppe UC, Hoyer J, Keller T, Blumenstein M, Schunkert H, Mahfoud F, Rump LC (2014) Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group “heart-kidney” of the German Cardiac Society and the German Society of Nephrology. Dtsch Med Wochenschr 139(7):e1–e8CrossRef
34.
go back to reference Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM (2016) European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation. G Ital Cardiol (Rome) 18(7):547–612 Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM (2016) European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation. G Ital Cardiol (Rome) 18(7):547–612
35.
go back to reference Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ (2004) Investigators, Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351(24):2481–2488CrossRef Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ (2004) Investigators, Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351(24):2481–2488CrossRef
36.
go back to reference Buiten MS, BieMK De, Van der Heijden AC, Rotmans JI, Bootsma M, Groeneveld JHM, Wolterbeek R, Rabelink TJ, Jukema JW, Schalij MJ, Van Erven L (2014) Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience. J Cardiovasc Electrophysiol 25(9):998–1004CrossRef Buiten MS, BieMK De, Van der Heijden AC, Rotmans JI, Bootsma M, Groeneveld JHM, Wolterbeek R, Rabelink TJ, Jukema JW, Schalij MJ, Van Erven L (2014) Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience. J Cardiovasc Electrophysiol 25(9):998–1004CrossRef
37.
go back to reference Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD (2015) Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol 10(7):1119–1127CrossRef Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD (2015) Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol 10(7):1119–1127CrossRef
38.
go back to reference Kiuchi MG, Chen S, Purerfellner H (2017) Incidence of ventricular arrhythmic events in CKD patients with ICD. Int J Cardiol 227:312–317CrossRef Kiuchi MG, Chen S, Purerfellner H (2017) Incidence of ventricular arrhythmic events in CKD patients with ICD. Int J Cardiol 227:312–317CrossRef
39.
go back to reference Sherif KA, Abo-Salem E, Panikkath R, Nusrat M, Tuncel M (2014) Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease. Clin Cardiol 37(7):417–421CrossRef Sherif KA, Abo-Salem E, Panikkath R, Nusrat M, Tuncel M (2014) Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease. Clin Cardiol 37(7):417–421CrossRef
40.
go back to reference Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P (2010) Frequent hemodialysis network daily Trial, determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 5(10):1821–1827CrossRef Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P (2010) Frequent hemodialysis network daily Trial, determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 5(10):1821–1827CrossRef
41.
go back to reference Fort J (2005) Chronic renal failure: a cardiovascular risk factor. Kidney Int Suppl 99:S25–S29CrossRef Fort J (2005) Chronic renal failure: a cardiovascular risk factor. Kidney Int Suppl 99:S25–S29CrossRef
42.
go back to reference Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116(1):85–97CrossRef Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116(1):85–97CrossRef
Metadata
Title
Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients
Authors
Kathrin Weidner
Michael Behnes
Christel Weiß
Christoph Nienaber
Linda Reiser
Armin Bollow
Gabriel Taton
Thomas Reichelt
Dominik Ellguth
Niko Engelke
Jonas Rusnak
Tobias Schupp
Seung-hyun Kim
Christian Barth
Jorge Hoppner
Muharrem Akin
Kambis Mashayekhi
Martin Borggrefe
Ibrahim Akin
Publication date
01-11-2019
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 11/2019
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01415-z

Other articles of this Issue 11/2019

Heart and Vessels 11/2019 Go to the issue